Robert T Foster, CEO and Director, Director at Hepion Pharmaceuticals, holds 50.47K shares in Hepion Pharmaceuticals (Ticker: HEPA), holds ― shares in Aurinia Pharmaceuticals (Ticker: AUPH). Most recently, Robert T Foster Bought ― shares of Hepion Pharmaceuticals on Sep 19, 2023 for an estimated value of 8.96K.
What is the percentage of profitable transactions made by Robert T Foster?
The percentage of profitable transactions made by Robert T Foster is 0%.
What is the average return per transaction made by Robert T Foster?
The average return per transaction made by Robert T Foster is -72.40%.
What stocks does Robert T Foster hold?
Robert T Foster holds: HEPA, AUPH stocks.
What was Robert T Foster’s latest transaction?
Robert T Foster latest transaction was an Informative Buy of $8.96K.
What was Robert T Foster's most profitable transaction?
Robert T Foster’s most profitable transaction was an Informative Buy of HEPA stock on February 18, 2021. The return on the trade was -53.10%.
What is Robert T Foster's role in Hepion Pharmaceuticals?
Robert T Foster's role in Hepion Pharmaceuticals is CEO and Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.